|
1.
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
2.
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
3.
|
Shellenberger TD, Wang M, Gujrati M, et
al: BRAK/CXCL14 is a potent inhibitor of angiogenesis and a
chemotactic factor for immature dendritic cells. Cancer Res.
64:8262–8270. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zlotnik A, Burkhardt AM and Homey B:
Homeostatic chemokine receptors and organ-specific metastasis. Nat
Rev Immunol. 11:597–606. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hromas R, Broxmeyer HE, Kim C, et al:
Cloning of BRAK, a novel divergent CXC chemokine preferentially
expressed in normal versus malignant cells. Biochem Biophys Res
Commun. 255:703–706. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Hara T and Nakayama Y: CXCL14 and insulin
action. Vitam Horm. 80:107–123. 2009. View Article : Google Scholar
|
|
8.
|
Sleeman MA, Fraser JK, Murison JG, et al:
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR
alpha-chemokine. Int Immunol. 12:677–689. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Frederick MJ, Henderson Y, Xu X, et al: In
vivo expression of the novel CXC chemokine BRAK in normal and
cancerous human tissue. Am J Pathol. 156:1937–1950. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Meuter S and Moser B: Constitutive
expression of CXCL14 in healthy human and murine epithelial
tissues. Cytokine. 44:248–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Kurth I, Willimann K, Schaerli P, Hunziker
T, Clark-Lewis I and Moser B: Monocyte selectivity and tissue
localization suggests a role for breast and kidney-expressed
chemokine (BRAK) in macrophage development. J Exp Med. 194:855–861.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Maerki C, Meuter S, Liebi M, et al: Potent
and broad-spectrum antimicrobial activity of CXCL14 suggests an
immediate role in skin infections. J Immunol. 182:507–514. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Shurin GV, Ferris RL, Tourkova IL, et al:
Loss of new chemokine CXCL14 in tumor tissue is associated with low
infiltration by dendritic cells (DC), while restoration of human
CXCL14 expression in tumor cells causes attraction of DC both in
vitro and in vivo. J Immunol. 174:5490–5498. 2005. View Article : Google Scholar
|
|
14.
|
Starnes T, Rasila KK, Robertson MJ, et al:
The chemokine CXCL14 (BRAK) stimulates activated NK cell migration:
implications for the downregulation of CXCL14 in malignancy. Exp
Hematol. 34:1101–1105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Juremalm M and Nilsson G: Chemokine
receptor expression by mast cells. Chem Immunol Allergy.
87:130–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tessema M, Klinge DM, Yingling CM, Do K,
Van Neste L and Belinsky SA: Re-expression of CXCL14, a common
target for epigenetic silencing in lung cancer, induces tumor
necrosis. Oncogene. 29:5159–5170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Balkwill FR: The chemokine system and
cancer. J Pathol. 226:148–157. 2012. View Article : Google Scholar
|
|
18.
|
Augsten M, Hagglof C, Olsson E, et al:
CXCL14 is an autocrine growth factor for fibroblasts and acts as a
multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci
USA. 106:3414–3419. 2009. View Article : Google Scholar
|
|
19.
|
Wente MN, Mayer C, Gaida MM, et al: CXCL14
expression and potential function in pancreatic cancer. Cancer
Lett. 259:209–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Komori R, Ozawa S, Kato Y, Shinji H,
Kimoto S and Hata R: Functional characterization of proximal
promoter of gene for human BRAK/CXCL14, a tumor-suppressing
chemokine. Biomed Res. 31:123–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Park CR, You DJ, Kim DK, et al: CXCL14
enhances proliferation and migration of NCI-H460 human lung cancer
cells overexpressing the glycoproteins containing heparan sulfate
or sialic acid. J Cell Biochem. 114:1084–1096. 2013. View Article : Google Scholar
|
|
22.
|
Mokhtar NM, Cheng CW, Cook E, Bielby H,
Smith SK and Charnock-Jones DS: Progestin regulates chemokine
(C-X-C motif) ligand 14 transcript level in human endometrium. Mol
Hum Reprod. 16:170–177. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Izukuri K, Suzuki K, Yajima N, et al:
Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma
cell transplants. [corrected]. Transgenic Res. 19:1109–1117.
2010.PubMed/NCBI
|
|
24.
|
Miyamoto C, Maehata Y, Ozawa S, et al:
Fasudil suppresses fibrosarcoma growth by stimulating secretion of
the chemokine CXCL14/BRAK. J Pharmacol Sci. 120:241–249. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Ikoma T, Ozawa S, Suzuki K, et al:
Calcium-calmodulin signaling induced by epithelial cell
differentiation upregulates BRAK/CXCL14 expression via the binding
of SP1 to the BRAK promoter region. Biochem Biophys Res Commun.
420:217–222. 2012. View Article : Google Scholar
|
|
26.
|
Ozawa S, Kato Y, Ito S, et al: Restoration
of BRAK/CXCL14 gene expression by gefitinib is associated with
antitumor efficacy of the drug in head and neck squamous cell
carcinoma. Cancer Sci. 100:2202–2209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Pelicano H, Lu W, Zhou Y, et al:
Mitochondrial dysfunction and reactive oxygen species imbalance
promote breast cancer cell motility through a CXCL14-mediated
mechanism. Cancer Res. 69:2375–2383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Issa JP: CpG island methylator phenotype
in cancer. Nat Rev Cancer. 4:988–993. 2004. View Article : Google Scholar : PubMed/NCBI
|
